Abeona Therapeutics closes $92 million public offering

via abeonatherapeutics.com

Story excerpt provided by Crain’s Cleveland Business.

Clinical-stage biopharmaceutical company Abeona Therapeutics Inc. (Nasdaq: ABEO) on Thursday, Oct. 19, announced the closing of a public stock offering that generated gross proceeds of about $92 million.

The offering of 5 million shares also included the full exercise of the underwriters’ option to buy 750,000 additional shares, at the public offering price of $16 per share, Abeona said in a news release.

Earlier in the week, Abeona said it intended to use the net proceeds of the offering “for working capital and corporate purposes, including, without limitation, development of its product candidates, manufacturing and general and administrative expenses.”

Click here to read the complete article.

Originally published October 19, 2017.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: